Our 2024 Investor Open Day met on May 31, 2024.
The topics at this open day covered the business introduction and strategic layout of our nuclear medicine segment, the development plan of the nuclear medicine industry in Chengdu Medical City, the global supply and manufacturing of our partner Telix and the cooperation between Telix and our group, as well as the radiopharmaceutical platform and the improvements in patient benefits from medical R&D achievements of our partner ITM.
We were honoured to have our management, the leadership of Chengdu Medical City, the management of Telix and ITM, as well as more than 130 investors and analysts participating in our communication and dialogue.
